Pfizer Inc. (NYSE
FE ) Q1 2025 Results Conference Call April 29, 2024 10:00 AM ET Company Participants Francesca DeMartino - Chief Investment Relations Officer and Senior Vice President Dr. Albert Bourla - Chairman and Chief Executive Officer Dave Denton - Chief Financial Officer and Executive Vice President Chris Boshoff - Chief Scientific Officer Aamir Malik - Chief U.S. Commercial Officer and Executive Vice President Alexandre de Germay - Executive Vice President & Chief International Commercial Officer Andrew Baum - Chief Strategy & Innovation Officer and Executive Vice President Conference Call Participants Vamil Divan - Guggenheim Evan Seigerman - BMO Capital Markets Tim Anderson - Bank of America Steve Scala - Cowen Umer Raffat - Evercore ISI Chris Schott - JPMorgan Geoff Meacham - Citi Trung Huynh - UBS Kerry Holford - Berenberg Akash Tewari - Jefferies Terence Flynn - Morgan Stanley Dave Reisinger - Leerink Mohit Bansal - Wells Fargo Courtney Breen - Bernstein Assad Haider - Goldman Sachs Operator Good day, everyone, and welcome to Pfizer's First Quarter 2025 Earnings Conference Call. Today's call is being recorded.
